Академический Документы
Профессиональный Документы
Культура Документы
• Restricted spectrum
• No standardized in-vitro susceptibility tests
• Most inhibit replication. Cure depends on host
immune system to eradicate. If patients are
immunocompromized, may have recurrences.
• Many need to be activated by viral and cellular
enzymes before exerting antiviral effect. Activity
of enzymes and concentration of substrates will
influence the efficacy.
Classification
• Purine and Pyrimidine Analogues (Herpes, CMV,
HIV, Resp. Syncitial)
• Non-nucleoside inhibitors of reverse transcriptase
(HIV)
• Direct inhibitor of DNA polymerase and RT –
Foscarnet
• Protease Inhibitors (HIV)
• Interferon-alpha (Hep. B&C, Herpes)
• Others: Amantadine, Rimantadine (Influenza)
Nucleoside Analogues
General Mechanism of Action
img011
1. Taken up by cells
2. Converted by viral and cellualr enzymes to the
triphosphate form
3. The triphosphate form inhibits:
• DNA polymerase
• Reverse transcriptase
• RNA polymerase
• Or it may get incorporated into growing DNA
leading to abnormal proteins or breakage.
Acyclovir
and Valacyclovir (prodrug, better availability)
A Guanine analogue with antiviral for Herpes group only
Acyclovir AcycloGMP AcycloGTP
Thymidine kinase Cellular kinases
Viral 200x affinity
of mammalian
Guanine
Other Nucleoside Analogues
Vidarabine Idoxuridine and
• Poor solubility, give i.v. with Trifluridine
big volume of fluids (2.5 L) • Topical agents for Herpes keratitis
⇒ risk of fluid overload • Trifluridine also for CMV and
• Toxicity: GI; Bone marrow; others
Hypokalemia; inappropriate • Trifluridine better for H. simplex II
ADH secretion; (psychosis; keratoconjuctivitis
painful neuropathy; Ribavirin
• Not a drug of choice for • Aerosol: inhibits replication of
anything. Replaced by Influenza A & B and RCV
Acyclovir because of toxicity • Triphosphate inhibits RNA
and problems in polymerase
administration. • Anemia due to hemolysis and BM
suppression
Foscarnet
• An inorganic pyrophosphate analog
• Active against Herpes (I, II, Varicella , CMV),
inlcuding those resistant to Acyclovir and Ganciclovir.
• Direct inhibition of DNA polymerase and RT
• Nephrotoxicity (25%) most common ADR
• Hypocalcemia (chelates divalent cations)
• Others: hypokalemia, hypomagnesemia
• Use: CMV retinitis and other CMV infections instead
of ganciclovir. H simplex resistant to Acyclovir. HIV.
Anti-retroviral Agents
• Zidovudine (AZT)
• Cellular enzyme phosphorylate to the triphosphate form
which inhibits RT and causes chain termination
• Adverse effect:
– Granulocytopenia and anemia: 45% in AIDS but 5% if
asymptomatic HIV
– Severe headache, nausea, insomnia, myalgias
• ↓mortality & opportunistic infections, gain weight, better
quality of life, delays signs and symptoms of AIDS
Other Retroviral RT Inhibitors
• Other nucleoside analogs: didanosine, stavudine,
zalcitabine: same as AZT but can cause peripheral
neuropathy and pancreatitis. Can be used with
AZT for enhanced effect and less toxicity.
• Non-nucleoside RT inhibitors: e.g. neviparine.
Noncompetitive binding to RT and direct
inhibition at a site different from AZT and others.
May be active against AZT-resistant strains. Can
be used in combination. Main adverse effect is
rash (75).
Protease Inhibitors
• Produce non-infectious particles or virions
• Reduces the number of new rounds of infection in
susceptible cells
• To be effective must be prolonged, profound and
constant.
• Pharmacokinetics important to maintain constant
concentrations within the effective range.
• Metabqolic adverse effects (DM, hyperglycemia)
and GI (diarrhea, pain vomiting).
Protease Inhibitors
Protease action
Panel C shows the translational products of the HIV gag–pol gene and the sites
at which the gene product is cleaved by the virus-encoded protease. p17
denotes capsid protein, p24 matrix protein, and p7 nucleocapsid; p2, p1, and
p6 are small proteins with unknown functions. The arrows denote cleavage
events catalyzed by the HIV-specific protease.
Fig. 3. HIV-1 virion forms. (a) Particles assembling and budding at the cell
membrane. (b) An immature virus particle. (c) Mature forms of HIV-1.
Other Drugs
Amantadine Interferons
• Prevents uncoating (?) &/or • Antiviral, anticancer and
assembly immunomodulating
• CNS Toxicity due to • Several sites of action in
dopaminergic action
viral cycle but mainly
• Prophylaxis of Influenza A inhibit translation of viral
during epidemics.
proteins
• If used within 48 hours may
help cure Influenza infection • Toxicity: flu-like syndrome,
• Rimantadine: analog with BM suppression; CNS
less CNS toxicity • Hepatitis B and C